Analysts expect Encompass Health Corp (NYSE:EHC) to post sales of $1.11 billion for the current quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Encompass Health’s earnings. The lowest sales estimate is $1.10 billion and the highest is $1.13 billion. Encompass Health reported sales of $1.05 billion during the same quarter last year, which would suggest a positive year over year growth rate of 5.7%. The business is scheduled to issue its next earnings report on Thursday, April 25th.
According to Zacks, analysts expect that Encompass Health will report full year sales of $4.53 billion for the current year, with estimates ranging from $4.51 billion to $4.56 billion. For the next year, analysts anticipate that the business will report sales of $4.75 billion, with estimates ranging from $4.68 billion to $4.80 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that follow Encompass Health.
Several research analysts recently commented on the stock. UBS Group assumed coverage on shares of Encompass Health in a research note on Thursday, November 15th. They issued a “buy” rating and a $86.00 target price on the stock. Barclays assumed coverage on shares of Encompass Health in a research note on Friday, December 14th. They issued an “equal weight” rating and a $75.00 target price on the stock. ValuEngine raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Monday, February 4th. Finally, Jefferies Financial Group assumed coverage on shares of Encompass Health in a research note on Thursday, December 20th. They issued a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. Encompass Health has an average rating of “Buy” and an average target price of $74.88.
Shares of NYSE EHC traded up $0.20 during mid-day trading on Wednesday, hitting $65.30. The stock had a trading volume of 897,683 shares, compared to its average volume of 766,292. The company has a quick ratio of 1.05, a current ratio of 0.98 and a debt-to-equity ratio of 1.54. Encompass Health has a 1 year low of $50.63 and a 1 year high of $82.46. The company has a market cap of $6.44 billion, a price-to-earnings ratio of 17.99, a PEG ratio of 1.68 and a beta of 0.76.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Article: 52-Week High/Low Prices For Stock Selection
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.